https://www.reuters.com/business/healthcare-pharmaceuticals/curevac-says-covid-vaccine-produced-immune-response-early-stage-trial-2023-01-06/
0
0
1/6/23 at 7:02pm
Organization
Reuters
Authors
Germany's CureVac AG said on Friday its second-generation COVID-19 vaccine produced virus-neutralizing antibodies against the BA.1 subvariant of Omicron, based on preliminary data from an early-stage trial.
Create an account
or login to join the discussion